Medicare Enrolled

Dr. Sheri Rowen, MD

Ophthalmology · Newport Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
4220 VON KARMAN AVE, Newport Beach, CA 92660
9498547400
In practice since 2006 (19 years)
NPI: 1548203904 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rowen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rowen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rowen

Dr. Sheri Rowen is an ophthalmology specialist in Newport Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rowen performed 994 Medicare services across 848 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rowen received a total of $1,068,570 from 44 pharmaceutical and/or device companies across 1574 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rowen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 994 Medicare services $1,068,570 industry payments

Medicare Practice Summary

Medicare Utilization ↗
994
Medicare services
Bottom 34% in CA for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
848
Unique beneficiaries
$133
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~52 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
200 $37 $140
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
189 $126 $439
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
171 $405 $2,150
Insertion of drug delivery implant into tear duct
A small implant containing medication is placed into the tear duct of the eye to deliver drugs directly to the eye over time.
129 $14 $500
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
70 $272 $514
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
65 $28 $120
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
55 $31 $75
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $76 $121
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
29 $97 $359
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
23 $26 $75
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
17 $75 $140
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $47 $65
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.2% high complexity
14.4% medium
68.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,068,570
Total received (2018-2024)
Avg $152,653/year across 7 years
Top 0% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,574
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$571,071 (53.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$398,674 (37.3%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$87,740 (8.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,085 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$142,048
2023
$324,462
2022
$173,567
2021
$78,264
2020
$24,888
2019
$209,704
2018
$115,638

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$100,874
Dompe US, Inc.
$10,895
Oyster Point Pharma, Inc.
$9,379
Alcon Vision LLC
$7,387
Glaukos Corporation
$5,133
Tarsus Pharmaceuticals, Inc.
$2,880
BIOTISSUE HOLDINGS INC.
$2,284
Alcon Research LLC
$2,250
Johnson & Johnson Surgical Vision, Inc.
$343
ABBVIE INC.
$184
Microsurgical Technology, Inc.
$122
RxSight Inc
$109
Mallinckrodt Hospital Products Inc.
$80
SUN PHARMACEUTICAL INDUSTRIES INC.
$79
Rayner Intraocular Lenses Limited
$32
Ocular Therapeutix, Inc.
$18
Top 3 companies account for 85.3% of 2024 payments
All-time payments by company (2018-2024) ›
RxSight Inc
$217,859
Bausch & Lomb Americas Inc.
$191,171
Bausch & Lomb, a division of Bausch Health US, LLC
$172,717
Oyster Point Pharma, Inc.
$125,203
Alcon Research LLC
$91,565
Alcon Vision LLC
$74,825
Shire North American Group Inc
$65,668
Dompe US, Inc.
$32,239
Novartis Pharmaceuticals Corporation
$18,262
Kala Pharmaceuticals, Inc.
$11,501
Allergan, Inc.
$6,984
Allergan Inc.
$6,758
Johnson & Johnson Surgical Vision, Inc.
$6,119
Glaukos Corporation
$5,601
ABBVIE INC.
$4,560
Omeros Corporation
$4,527
Carl Zeiss Meditec, Inc.
$4,488
Sun Pharmaceutical Industries Inc.
$3,237
Tarsus Pharmaceuticals, Inc.
$2,880
Sight Sciences, Inc.
$2,519
BIOTISSUE HOLDINGS INC.
$2,284
NOVARTIS PHARMACEUTICALS CORPORATION
$2,273
Horizon Therapeutics plc
$2,021
LENSAR, Inc.
$1,764
Eyevance Pharmaceuticals LLC
$1,692
Thea Pharma Inc.
$1,473
Harrow Eye, LLC
$1,440
EyePoint Pharmaceuticals US, Inc.
$1,326
STAAR SURGICAL COMPANY
$1,289
Ivantis, Inc
$1,276
AbbVie Inc.
$760
Ocular Therapeutix, Inc.
$313
Mallinckrodt Hospital Products Inc.
$290
Alcon Laboratories Inc
$283
SUN PHARMACEUTICAL INDUSTRIES INC.
$240
Aerie Pharmaceuticals, Inc.
$213
Carl Zeiss Meditec USA, Inc.
$204
GLAUKOS CORPORATION
$182
Apellis Pharmaceuticals, Inc.
$151
Microsurgical Technology, Inc.
$122
Beaver-Visitec International, Inc.
$113
Bausch Health US, LLC
$102
Rayner Intraocular Lenses Limited
$59
TissueTech, Inc.
$17
Top 3 companies account for 54.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AKREOS AO · ALPHAGAN P · AMO PHACO NEEDLE · ARGOS · ARTEVO 800 · AcrySof · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · BESIVANCE · BLINK NUTRITEARS · BROMSITE · BromSite · BromSite (bromfenac ophthalmic solution) 0.075% · CAPITAL EQUIPMENT CART · CATALYS SYSTEM · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · CIRRUS HD-OCT · CRYSTALENS · Cataract Suite · Centurion · Cequa · Clareon · DEXTENZA · DEXYCU · DOCTORS ALLERGY FORMULA · DUREZOL · DURYSTA · ENVISTA · ENVISTA TORIC · EYSUVIS · FORUM · Flarex · HYDRUS Microstent · Healon Duet Pro · Hydrus · IACCESS · IHEEZO · ILUX · INVELTYS · IOL · IOLMaster 500 · IOLMaster 700 · ISTENT · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · LENSAR LASER SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE) · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMERA 700 · LUMIGAN · Luxor · MEL 80 · MIEBO · OMIDRIA · OMNI · OMNI SURGICAL SYSTEM · OMNI Surgical System · OMNI(R) SURGICAL SYSTEM (US) · ORA System VerifEye · OXERVATE · Omidria · Ophthalmic Surgical Adjuncts · Oxervate · PROLENSA · PanOptix · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · RXSIGHT INJECTOR HANDPIECE · ReSTOR · ReSure Sealant · STELLARIS · STELLARIS ELITE · STELLARIS PC · Simbrinza · Syfovre · Systane · TEARCARE SYSTEM · TECNIS IOL · TEPEZZA · TORIC · TRULIGN TORIC · TYRVAYA · TearCare SmartLid · Tecnis 1-piece IOL · Tecnis Simplicity · Tecnis Symphony IOL · VEVYE · VUITY · VYZULTA · VisuMax · WaveLight EX500 Excimer Laser · Wavelight · Wavelight Refractive Suite · XDEMVY · XELPROS · XIIDRA · XIPERE · ZIRGAN · ZYLET · enVista Aspire IOL · enVista MX60 IOL · iDose · iStent Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · miLOOP · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for ophthalmology in CA.

Looking for an ophthalmology specialist in Newport Beach?
Compare ophthalmologists in the Newport Beach area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
362
Per 100K population
11.4
County median income
$113,702
Nearest hospital
COLLEGE HOSPITAL COSTA MESA
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rowen is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rowen experienced with corneal topography and eye depth measurement?
Based on Medicare claims data, Dr. Rowen performed 200 corneal topography and eye depth measurement services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rowen receive payments from pharmaceutical companies?
Yes. Dr. Rowen received a total of $1,068,570 from 44 companies across 1,574 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rowen's costs compare to other ophthalmologists in Newport Beach?
Dr. Rowen's average Medicare payment per service is $133. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rowen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →